Congratulations to the 2017 IDSA/HIVMA Society Award Winners
IDSA, the IDSA Education and Research Foundation, and HIVMA are honoring 12 individuals for outstanding achievements at IDWeek 2017 in San Diego.
Among the honors is the Alexander Fleming Award, a lifetime achievement recognition granted to IDSA members or fellows for a career that reflects major contributions to the acquisition and dissemination of knowledge about infectious diseases. This year, the Fleming Award is being presented to Barbara Murray, MD, FIDSA.
Widely recognized for her significant contributions spanning microbial physiology, virulence, antimicrobial resistance, and drug development throughout her career, Dr. Murray’s achievements have had an enormous impact on the field. Her globally recognized investigations have outlined the basic science that forms much of the foundation for our current understanding of the genetic basis and mechanisms of enterococcal drug resistance and pathogenesis. Dr. Murray’s contributions have established many of the modern therapeutic paradigms for these important pathogens. She also has expanded our knowledge of antimicrobial resistance in many other key bacterial pathogens. Her impact extends to new antibiotic development as well, through efforts to help characterize new and promising compounds using a substantial collection of susceptible and resistant organisms that she maintains and through guidance to pharmaceutical companies.
Dr. Murray is an active leader in the field at the local, national, and international levels. She has served on committees for the Food and Drug Administration, the National Institutes of Health, and has served in multiple leadership roles within IDSA including serving as president from 2013 to 2014. Since 2015, she has been chair of the Society’s Antimicrobial Resistance Committee.
Dr. Murray is the J. Ralph Meadows Professor in Internal Medicine and director of the Division of Infectious Diseases at the McGovern Medical School at the University of Texas Health Science Center at Houston. Since 1980, Dr. Murray has been on the faculty of the University of Texas Medical School in Houston. She has directly sponsored or mentored more than 50 trainees in the field, adding to her enduring legacy.
Other awards presented during IDWeek 2017 are:
The Society Citation Award is given in recognition of exemplary contribution to IDSA, outstanding discovery in the field of infectious diseases, or a lifetime of outstanding achievement in a given area – whether research, clinical investigation or clinical practice. This year awards will be presented to:
Wendy S. Armstrong, MD, FIDSA, a leading physician, researcher, and educator who has worked tirelessly on behalf of patients, trainees, and the profession. Dr. Armstrong is a professor of medicine in the Division of Infectious Diseases and vice chair of education and integration at Emory University School of Medicine and also serves as medical director of the Ponce de Leon Center, one of the largest urban HIV/AIDS clinics in the country. In addition to these many responsibilities, she has committed countless hours to help move the ID specialty’s educational programs forward and mobilize the IDSA community to attract trainees to the field. In her roles as chair of IDSA’s ID Training Program Directors Committee and the Task Force on ID Fellowship Recruitment, Dr. Armstrong has spearheaded multiple initiatives focused on improving fellowship education, assessing and enhancing the current workforce, and growing the specialty.
Patrick Joseph, MD, FIDSA, FSHEA, is a highly respected clinician and diagnostic laboratory expert. Dr. Joseph is an associate clinical professor of medicine at the University of California, San Francisco (UCSF), manages a private practice in San Ramon, CA, and is the medical director of four molecular diagnostic laboratories in Northern California. With a long and distinguished career as a dedicated clinician, always willing to counsel the next generation of ID physicians, he is considered a role model by his peers. An expert in diagnostic laboratory medicine, his activities and leadership in this important area have significantly improved the standards in many diagnostic laboratories in the western United States. A fellow of IDSA and SHEA, Dr. Joseph’s contributions and insights have benefited several IDSA committees, including the Clinical Affairs Committee, the Education Program Committee, and the Diagnostics Task Force.
Dean L. Winslow, MD, FIDSA, a compassionate, committed clinician, teacher, and military veteran who has been a champion for patients with HIV and victims of war and disaster. Dr. Winslow is vice chair of the Department of Medicine and a professor of medicine in the Division of Hospital Medicine and the Division of Infectious Diseases and Geographic Medicine at Stanford University. He is also academic physician-in-chief at Stanford/ValleyCare, a community teaching hospital. A highly regarded attending physician at Stanford and the Palo Alto Veterans Administration Medical Center, Dr. Winslow has received multiple teaching awards. His wide-ranging knowledge and experience, combined with his passion for teaching and patient care, are legendary among ID fellows and residents. From 2003 to 2011, Dr. Winslow deployed to Iraq and Afghanistan six times as a flight surgeon in the Air National Guard in support of combat operations there, including serving as the commander of an Air Force combat hospital unit in Baghdad in 2008. Closer to home, Dr. Winslow coordinated military public health and force protection in Louisiana after Hurricane Katrina. He has been awarded numerous military decorations for his service. A passionate supporter of human rights and health, he has, since 2006, arranged for medical care, transportation, and housing in the US for more than 20 Iraqi children and adults with complicated medical conditions for which surgical care was not available in Iraq. He has been recognized by the Iraqi Army for his humanitarian service to the Iraqi people.
The D.A. Henderson Award for Outstanding Contributions to Public Health. Named to honor the memory of Dr. Henderson, who led the successful eradication of smallpox, this new award recognizes a lifetime of achievement in public health. F. Marc LaForce, MD, FIDSA, a visionary leader who was the driving force behind a groundbreaking, low-cost vaccine that today protects hundreds of millions of people from death and disability from group A meningococcal disease, is the recipient of this award. Following a major outbreak in the sub-Saharan Africa in the mid-1990s, in which about 250,000 people were sickened and 25,000 died, Dr. LaForce became director of the Meningitis Vaccine Project, a unique partnership between PATH and the World Health Organization (WHO), supported by the Bill & Melinda Gates Foundation, with the goal of developing an affordable vaccine. Dr. LaForce devised a novel strategy that brought together a vaccine manufacturer in India and other partners across four continents to develop and deliver a vaccine at less than one-tenth of the cost usually required to bring a new vaccine to market. Under his leadership from 2001 to 2012, the project successfully developed, tested, licensed, and introduced a safe and effective conjugate meningococcal vaccine, available at less than 50 cents per dose. By the end of 2016, more than 320 million young Africans in the 26 countries that make up the continent’s “meningitis belt” were expected to have received the vaccine— preventing an estimated 1.3 million cases of disease, 250,000 cases of disability, and 130,000 deaths.
The Oswald Avery Award recognizes outstanding achievement in infectious diseases by a member or fellow of IDSA who is 45 or younger. This year, William J. Steinbach, MD, FIDSA, FPIDS, professor of pediatrics, molecular genetics, and microbiology, and chief of the Division of Pediatric Infectious Diseases at Duke University School of Medicine in Durham, NC, is being recognized for quickly becoming an international leader as an investigator studying the molecular basis and clinical manifestations of invasive fungal infections. The principal investigator for three current NIH R01 grants, Dr. Steinbach’s translational work over the past 10 years has focused on defining the molecular controls of Aspergillus hyphal growth and characterizing a variety of Aspergillus cell signaling pathways, including calcineurin, Ras, and heat shock protein 90. Recognizing a specific gap in the pediatric ID field, he founded and still directs the International Pediatric Fungal Network. He has also co-founded, and continues to co-chair, the biennial Advances Against Aspergillosis international conference, dedicated to Aspergillus clinical care and research.
The Watanakunakorn Clinician Award honors the memory of Dr. Chatrchai Watanakunakorn and is given by the IDSA Education and Research Foundation to an IDSA member or fellow in recognition of outstanding achievement in the clinical practice of infectious diseases. This year’s awardee is Douglas R. Osmon, MD, MPH, FIDSA, of the Mayo Clinic in Rochester, MN. Dr. Osmon is a superb, meticulous, compassionate clinician whose passion for clinical care has greatly advanced the treatment of musculoskeletal infections. His strong patient advocacy has earned the admiration of patients, colleagues, and peers at other institutions. The Orthopedic Infectious Diseases Practice he developed and leads at Mayo as chair, which recognizes the necessary link between ID and surgical specialists in caring for patients with orthopedic infections, has set the bar for many other institutions.
The Walter E. Stamm Mentor Award, which honors late past-president Walter E. Stamm, MD, is presented to an IDSA member or fellow who has been exceptional in guiding professional growth of infectious diseases professionals. This year’s winner is Stephen B. Calderwood, MD, FIDSA, chief of infectious diseases, professor of medicine, and director of undergraduate medical education at Massachusetts General Hospital. Dr. Calderwood has created a culture within his clinical division that encourages mentorship and serves as a model for other institutions. He has made the career development of others a central goal of his collaborative research activities, encouraging his mentees to develop into independent physician-scientists and mentors themselves. A committed advocate for the appointment and advancement of women faculty, he is considered a role model for how to be an effective and inclusive leader. Many former trainees cite his influence in their own mentoring activities, extending his impact even further.
The Clinical Teacher Award honors a career dedicated to excellence in teaching fellows, residents or medical students, and motivating them to teach the next generation. This year’s honoree is Michael J. Barza, MD, FIDSA, vice chair for clinical affairs at Tufts Medical Center and the Sara Murray Jordan Professor of Medicine at Tufts University School of Medicine in Boston. Dr. Barza’s legendary teaching has been a major influence on scores of medical students, residents, and infectious disease fellows over the past 45 years. Equally adept at the podium and the bedside, his ability to synthesize difficult concepts and present them in an exceedingly clear manner is considered unparalleled. A superb clinician, he is well known for the breadth of his differential diagnosis, his clear thinking and assessment of a problem, the logic with which he comes to conclusions, and his ability to impart these traits to others. For many years, he served as deputy editor of Clinical Infectious Diseases.
The Clinical Practice Innovation Award is a new award that recognizes members who devote the majority of their time to patient care and have, within the last five years, significantly advanced the clinical practice of infectious diseases by making innovations in clinical practice design or management, or by fostering change to better recognize the value of infectious diseases practice. Kavita P. Bhavan, MD, MHS, FIDSA, the inaugural recipient of this award, is an expert in outpatient parenteral antimicrobial therapy (OPAT), whose innovative approach brought this vital treatment to uninsured patients. Despite the benefits of OPAT for patients on long-term antibiotics, this therapy is typically not available to the uninsured who cannot afford it. As medical director of the Outpatient Parenteral Antimicrobial Clinic at Parkland Hospital, a large safety-net hospital in Dallas, Dr. Bhavan developed a successful program in which even the most underserved patients can receive outpatient antibiotic therapy. Engaging and empowering patients, the multidisciplinary program offers uninsured patients the option to be taught to self-administer intravenous antibiotics, using a standardized protocol to ensure patient mastery, with weekly in-clinic follow up. A nationally recognized OPAT expert, and a member of the Institute for Healthcare Improvement, Dr. Bhavan serves on the committee currently updating IDSA’s OPAT guidelines and is an Associate Professor at UT Southwestern in Infectious Diseases.
HIVMA awards are being presented to Monica Gandhi, MD, MPH, of the University of California, San Francisco (UCSF) and San Francisco General Hospital, and Raphael J. Landovitz, MD, MSc, of the David Geffen School of Medicine at the University of California Los Angeles (UCLA) for their significant contributions to the field of HIV medicine.
Dr. Gandhi is receiving the 2017 HIVMA Clinical Educator Award, which recognizes those who have demonstrated significant achievement in the area of clinical care and provider education. Dr. Gandhi is an internationally recognized clinician and educator who has woven teaching and mentoring into all aspects of her work. She is currently a professor of clinical medicine in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital. She is also medical director of the Ward 86 HIV Clinic, where she oversees care for more than 2,800 patients. In this safety-net clinic and hospital setting, she has devoted herself to caring for an HIV-infected and at-risk patient population that includes the urban poor, homeless, women, racial and ethnic minorities, and immigrants—people often hard to engage and retain but who greatly need high-quality medical care. Dr. Gandhi’s commitment to teaching and mentoring extends well beyond UCSF. Supported by a National Institutes of Health grant, she developed a mentoring program for early career investigators of diversity and a “Mentoring the Mentors” national workshop series for mid-career and senior HIV investigators and has led trainings in the US, Peru, Kenya, India, and South Africa supported by funding from the Fogarty International Center.
Dr. Landovitz is receiving the 2017 HIVMA Research Award, which recognizes members who have made outstanding contributions to HIV medicine in clinical or basic research early in their careers. Dr. Landovitz is a skilled HIV clinician and researcher who has been a leader in advancing biomedical HIV prevention. An associate professor of medicine in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA and associate director of the UCLA Center for Clinical AIDS Research & Education, Dr. Landovitz also serves as co-director of the UCLA Center for HIV Identification, Prevention, and Treatment Services. His research has focused on HIV behavioral science, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP), including novel research findings related to motivators and barriers for these approaches, the efficacy of contingency management to facilitate their use in substance users, and HIV risk trajectories that warrant PrEP. Considered a leading PrEP expert, Dr. Landovitz has conducted some of his work in collaboration with Los Angeles County, through establishing PEP and PrEP demonstration projects in collaboration with the Department of Health, including the use of real-time drug levels to trigger staged-level adherence interventions. Since 2009, when he obtained his National Institutes of Health career development award, he has published more than 40 primary research studies, reviews, and editorials.